{"id":10715,"date":"2025-05-01T17:58:18","date_gmt":"2025-05-01T15:58:18","guid":{"rendered":"https:\/\/www.adacyte.com\/what-do-ulcerative-colitis-patients-prefer-in-their-treatments\/"},"modified":"2025-11-10T01:28:57","modified_gmt":"2025-11-10T00:28:57","slug":"quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique","status":"publish","type":"post","link":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/","title":{"rendered":"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ?"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h2 class=\"wp-block-heading\"><strong><strong><strong><strong>Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite h\u00e9morragique en ce qui concerne leur traitement ?<\/strong><\/strong><\/strong><\/strong><\/h2>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Au cours des derni\u00e8res d\u00e9cennies, les options th\u00e9rapeutiques pour les patients atteints de rectocolite h\u00e9morragique (RCH) ont consid\u00e9rablement augment\u00e9, cr\u00e9ant de nouveaux d\u00e9fis \u00e0 la fois pour les patients et les m\u00e9decins lorsqu&rsquo;il s&rsquo;agit de d\u00e9cider d&rsquo;un traitement. Une \u00e9tude r\u00e9cente men\u00e9e \u00e0 l&rsquo;Universit\u00e9 de Leiden aux Pays-Bas a examin\u00e9 les priorit\u00e9s des patients atteints de RCH lors du choix d&rsquo;un traitement et \u00e0 quel moment ils envisageraient une intervention chirurgicale l&rsquo;\u00e9chec de plusieurs options th\u00e9rapeutiques, \u00e9tant entendu que la d\u00e9cision rel\u00e8ve de l&rsquo;appr\u00e9ciation clinique du clinicien.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h2 class=\"wp-block-heading\"><strong><strong><strong><strong><strong>Qu\u2019est-ce qui a \u00e9t\u00e9 \u00e9tudi\u00e9 dans cette \u00e9tude ?<\/strong><\/strong><\/strong><\/strong><\/strong><\/h2>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>L&rsquo;\u00e9tude a port\u00e9 sur 172 patients adultes atteints de RCH, \u00e0 qui l\u2019on a demand\u00e9 de choisir entre diff\u00e9rentes options de traitement hypoth\u00e9tiques en fonction de diff\u00e9rentes caract\u00e9ristiques :<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li>La voie et le site d\u2019administration (voie orale, injection sous-cutan\u00e9e ou perfusion intraveineuse).<\/li>\n\n\n\n<li>La probabilit\u00e9 d\u2019une r\u00e9duction des sympt\u00f4mes \u00e0 court et \u00e0 long terme (sur huit semaines ou un an).<\/li>\n\n\n\n<li>Le risque d\u2019infections et d\u2019autres effets ind\u00e9sirables.<\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h2 class=\"wp-block-heading\"><strong><strong><strong><strong>Principaux r\u00e9sultats : Qu\u2019est-ce qui compte le plus pour les patients ?<\/strong><\/strong><\/strong><\/strong><\/h2>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Les patients ont indiqu\u00e9 que la caract\u00e9ristique la plus importante lors du choix d\u2019un traitement est la <strong>r\u00e9duction des sympt\u00f4mes apr\u00e8s un an <\/strong>(27,7 % d\u2019importance). En deuxi\u00e8me position, ils ont mentionn\u00e9 la <strong>probabilit\u00e9 d\u2019infection <\/strong>(22,3 %) et troisi\u00e8me position, la <strong>r\u00e9duction des sympt\u00f4mes au cours des huit premi\u00e8res semaines <\/strong>(19,5 %).<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>En outre, il a \u00e9t\u00e9 constat\u00e9 que :<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li>La voie d\u2019administration est \u00e9galement un facteur important, avec une pr\u00e9f\u00e9rence pour l\u2019administration orale par rapport \u00e0 l\u2019administration sous-cutan\u00e9e ou intraveineuse.<\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\">\n<li>14,3 <strong>% des patients ont d\u00e9clar\u00e9 qu\u2019ils n\u2019envisageraient pas une intervention chirurgicale,<\/strong> m\u00eame en cas d\u2019\u00e9chec de huit traitements m\u00e9dicaux.<\/li>\n\n\n\n<li><strong>Seuls 9 patients opteraient pour la chirurgie, <\/strong>sans avoir essay\u00e9 aucune th\u00e9rapie m\u00e9dicale.<\/li>\n<\/ul>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>En r\u00e9sum\u00e9, l\u2019\u00e9tude souligne que la r\u00e9duction des sympt\u00f4mes \u00e0 long terme est le facteur le plus important pour les patients atteints de RCH lorsqu\u2019ils choisissent un traitement, avant les effets ind\u00e9sirables ou la voie d&rsquo;administration. En plus, En plus, les patients qui n&rsquo;ont pas d&rsquo;exp\u00e9rience avec les produits biologiques ou les petites mol\u00e9cules sont plus susceptibles privil\u00e9gier la voie d&rsquo;administration que ceux qui ont une exp\u00e9rience avec ces traitements.&nbsp;<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h2 class=\"wp-block-heading\"><strong><strong><strong><strong>Pourquoi cette \u00e9tude est-elle importante ?<\/strong><\/strong><\/strong><\/strong><\/h2>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Ces r\u00e9sultats aident les cliniciens \u00e0 comprendre ce que les patients atteints de RCH valorisent le plus lorsqu\u2019ils choisissent leur traitement. Le fait de savoir que <strong>la r\u00e9duction des sympt\u00f4mes \u00e0 long terme est la principale priorit\u00e9<\/strong> permet de concevoir des strat\u00e9gies qui garantissent que les pr\u00e9f\u00e9rences individuelles sont prises en compte afin d\u2019optimiser l&rsquo;adh\u00e9sion au traitement et la qualit\u00e9 de vie des patients.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>En conclusion, cette \u00e9tude souligne l\u2019importance de privil\u00e9gier les traitements hautement efficaces \u00e0 long terme et un risque d\u2019infection plus faible, ainsi qu\u2019aux traitements administr\u00e9s par voie orale. En comprenant mieux les pr\u00e9f\u00e9rences des patients, les cliniciens peuvent prendre des d\u00e9cisions avec eux, garantissant ainsi un traitement plus appropri\u00e9 et plus satisfaisant.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<h2 class=\"wp-block-heading\"><strong>R\u00e9f\u00e9rence\u00a0:<\/strong><\/h2>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>1. Tessa Straatmijer , M. Elske van den Akker -van Marle , Cyriel Y. Ponsioen , Danielle van der Horst, Menne PM. Sharpenzeel , Marjolijn Duijvestein &amp; Andrea E. van der Meulen -de Jong (2024) Patient pr\u00e9f\u00e9rences en mati\u00e8re de traitement options de la colite ulc\u00e9reuse : un choix discret exp\u00e9rience , scandinave Journal de gastroent\u00e9rologie , 59:3, 288-295, <a href=\"https:\/\/doi.org\/10.1080\/00365521.2023.2286191\">https:\/\/doi.org\/10.1080\/00365521.2023.2286191<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite h\u00e9morragique en ce qui concerne leur traitement ? Au cours des derni\u00e8res d\u00e9cennies, les options th\u00e9rapeutiques pour les patients atteints de rectocolite h\u00e9morragique (RCH) ont consid\u00e9rablement augment\u00e9, cr\u00e9ant de nouveaux d\u00e9fis \u00e0 la fois pour les patients et les m\u00e9decins lorsqu&rsquo;il s&rsquo;agit de d\u00e9cider d&rsquo;un traitement. [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":10708,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[642],"tags":[],"class_list":["post-10715","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouveautes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ? - Adacyte<\/title>\n<meta name=\"description\" content=\"Une \u00e9tude montre que les patients atteints de RCH privil\u00e9gient l&#039;efficacit\u00e9 \u00e0 long terme, un faible risque infectieux et les traitements oraux.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ? - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Une \u00e9tude montre que les patients atteints de RCH privil\u00e9gient l&#039;efficacit\u00e9 \u00e0 long terme, un faible risque infectieux et les traitements oraux.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-01T15:58:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-10T00:28:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1400\" \/>\n\t<meta property=\"og:image:height\" content=\"933\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Adacyte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Adacyte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\"},\"author\":{\"name\":\"Adacyte\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f\"},\"headline\":\"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ?\",\"datePublished\":\"2025-05-01T15:58:18+00:00\",\"dateModified\":\"2025-11-10T00:28:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\"},\"wordCount\":647,\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg\",\"articleSection\":[\"Nouveautes\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\",\"url\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\",\"name\":\"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ? - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg\",\"datePublished\":\"2025-05-01T15:58:18+00:00\",\"dateModified\":\"2025-11-10T00:28:57+00:00\",\"description\":\"Une \u00e9tude montre que les patients atteints de RCH privil\u00e9gient l'efficacit\u00e9 \u00e0 long terme, un faible risque infectieux et les traitements oraux.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg\",\"width\":1400,\"height\":933},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f\",\"name\":\"Adacyte\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g\",\"caption\":\"Adacyte\"},\"url\":\"https:\/\/www.adacyte.com\/fr\/author\/adacyte\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ? - Adacyte","description":"Une \u00e9tude montre que les patients atteints de RCH privil\u00e9gient l'efficacit\u00e9 \u00e0 long terme, un faible risque infectieux et les traitements oraux.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/","og_locale":"fr_FR","og_type":"article","og_title":"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ? - Adacyte","og_description":"Une \u00e9tude montre que les patients atteints de RCH privil\u00e9gient l'efficacit\u00e9 \u00e0 long terme, un faible risque infectieux et les traitements oraux.","og_url":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/","og_site_name":"Adacyte","article_published_time":"2025-05-01T15:58:18+00:00","article_modified_time":"2025-11-10T00:28:57+00:00","og_image":[{"width":1400,"height":933,"url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg","type":"image\/jpeg"}],"author":"Adacyte","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Adacyte","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#article","isPartOf":{"@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/"},"author":{"name":"Adacyte","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f"},"headline":"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ?","datePublished":"2025-05-01T15:58:18+00:00","dateModified":"2025-11-10T00:28:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/"},"wordCount":647,"publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"image":{"@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg","articleSection":["Nouveautes"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/","url":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/","name":"Quelles sont les pr\u00e9f\u00e9rences des patients atteints de rectocolite ulc\u00e9ro-h\u00e9morragique ? - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage"},"image":{"@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg","datePublished":"2025-05-01T15:58:18+00:00","dateModified":"2025-11-10T00:28:57+00:00","description":"Une \u00e9tude montre que les patients atteints de RCH privil\u00e9gient l'efficacit\u00e9 \u00e0 long terme, un faible risque infectieux et les traitements oraux.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/fr\/quelles-sont-les-preferences-des-patients-atteints-de-rectocolite-ulcero-hemorragique\/#primaryimage","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2025\/04\/preferenciaspacientescu.jpg","width":1400,"height":933},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/faa89aca28655473819d4ecfb649a79f","name":"Adacyte","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cbd64ba36380d4e22aa2655fe2b008a576e8afc76e8b0d85bed05f1274f78bb4?s=96&d=mm&r=g","caption":"Adacyte"},"url":"https:\/\/www.adacyte.com\/fr\/author\/adacyte\/"}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts\/10715","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/comments?post=10715"}],"version-history":[{"count":2,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts\/10715\/revisions"}],"predecessor-version":[{"id":10723,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/posts\/10715\/revisions\/10723"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media\/10708"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=10715"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/categories?post=10715"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/tags?post=10715"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}